Latest Nanotechnology News RSS Feed - Nanotechnology News

Preliminary Data Abstract from BIND-014 Phase 2 Study in Non-Small Cell Lung Cancer

Preliminary Data Abstract from BIND-014 Phase 2 Study in Non-Small Cell Lung Cancer

BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, announced the online availability of an abstract providing preliminary data from the Q3W arm of its ongoing Phase 2 study of BIND-014 in non-small cell lung cancer (NSCLC). [More]
1366 Technologies Reports 18% Competitive Cell Efficiency for 156mm Multi-Crystalline Wafers

1366 Technologies Reports 18% Competitive Cell Efficiency for 156mm Multi-Crystalline Wafers

1366 Technologies today announced competitive cell efficiencies of 18% for its industry-standard, 156mm multi-crystalline wafers, as well as a solar industry first: the elimination of the “low efficiency tail” for cell manufacturers. [More]
Synopsys Offers DesignWare AEON FTP Trim NVM IP for TowerJazz 180nm SL Process Technology

Synopsys Offers DesignWare AEON FTP Trim NVM IP for TowerJazz 180nm SL Process Technology

Synopsys, Inc., a global leader providing software, IP and services used to accelerate innovation in chips and electronic systems, today announced the availability of the silicon-proven DesignWare® AEON® Few Time Programmable (FTP) Trim Non-Volatile Memory (NVM) IP for TowerJazz 180-nanometer (nm) SL process technology. [More]
Cavitation Technologies’ Strategic Partner Enters into Sales Agreement for Nano Reactor System

Cavitation Technologies’ Strategic Partner Enters into Sales Agreement for Nano Reactor System

Cavitation Technologies, Inc. (CVAT) Berlin: (Stuttgart:WTC) announced today that the Desmet Ballestra Group, CTi's strategic partner since 2010 and licensee of the company's vegetable oil refining technology, has entered into a sales agreement with a soybean oil refinery in Mexico. This oil refinery will process approximately 600MTPD of soybean oil and Desmet anticipates system installation in the 3rd quarter of CTi's fiscal year 2015. [More]
Latest Royal Society Research Professorship Awards Announced

Latest Royal Society Research Professorship Awards Announced

Royal Society Research Professorships have been awarded to two world-class scientists including Nobel-prize-winning physicist Professor Sir Konstantin Novoselov FRS. [More]
Nanyang Technological University and University of Southampton Launch The Photonics Institute

Nanyang Technological University and University of Southampton Launch The Photonics Institute

The next generation of ultra-fast Internet or ground-breaking electronic circuits, powered by light instead of electricity, could very well be built on research done at Nanyang Technological University (NTU) in conjunction with the University of Southampton. [More]
University of Cambridge Professor Awarded  5th Ahmed Zewail Prize in Molecular Sciences

University of Cambridge Professor Awarded 5th Ahmed Zewail Prize in Molecular Sciences

Elsevier, a world-leading provider of scientific, technical and medical information products and services, and the editors of the leading international journal Chemical Physics Letters are pleased to announce the winner of the 5th Ahmed Zewail Prize in Molecular Sciences. [More]
New Startup to Commercialize SLIPS Technology for Repelling Liquids and Solids

New Startup to Commercialize SLIPS Technology for Repelling Liquids and Solids

The Wyss Institute for Biologically Inspired Engineering at Harvard University today announced that its 'SLIPS' technology, a novel coating that repels almost every type of liquid and solid, will be commercialized by a newly formed private company, SLIPS Technologies, Inc. [More]
Gold Nanoparticle Chains Facilitate Highly Confined Light Propagation

Gold Nanoparticle Chains Facilitate Highly Confined Light Propagation

Researchers from Singapore and Bristol in association with the Centre d'Elaboration de Matériaux et d'Etudes Structurales (CEMES, CNRS) have demonstrated the confinement of light energy to nano scale level by aligning crystalline gold nanoparticles and fusing them into long chains. The research was published in the Nature Materials website. [More]
Ion Channels with Short Carbon Nanotubes Can be Inserted into Live Cell Membranes

Ion Channels with Short Carbon Nanotubes Can be Inserted into Live Cell Membranes

A team led by the Lawrence Livermore scientists has created a new kind of ion channel based on short carbon nanotubes, which can be inserted into synthetic bilayers and live cell membranes to form tiny pores that transport water, protons, small ions and DNA. [More]
New Report Analyzes Worldwide Markets for Nanotechnology

New Report Analyzes Worldwide Markets for Nanotechnology

Research and Markets has announced the addition of the "Nanotechnology - Global Strategic Business Report" report to their offering. [More]
TowerJazz and Physical Logic Report Milestone in Mass Production of MEMS-Based Accelerometer Family

TowerJazz and Physical Logic Report Milestone in Mass Production of MEMS-Based Accelerometer Family

TowerJazz, the global specialty foundry leader, and Physical Logic Ltd., a developer of MEMS-based sensor applications, announced today a milestone achievement for mass production of its first generation high performance MEMS-based accelerometer family (MAXL-OL-2000). [More]
Novavax' H7N9 VLP Vaccine Candidate Adjuvanted with Matrix-M Granted FDA Fast Track Designation

Novavax' H7N9 VLP Vaccine Candidate Adjuvanted with Matrix-M Granted FDA Fast Track Designation

Novavax, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to Novavax' H7N9 Virus-Like Particle Vaccine Candidate (H7N9 VLP) adjuvanted with Matrix-M™. The H7N9 VLP is being developed under the company's contract with the U.S. Department of Health and Human Services, Biomedical Advanced Research and Development Authority (BARDA) (Contract No. HHSO100201100012C) for the development of Novavax' recombinant vaccines to address seasonal influenza and influenza strains with pandemic potential. [More]
Vantage Health Enters into Strategic Partnership with Theranostics Laboratory

Vantage Health Enters into Strategic Partnership with Theranostics Laboratory

Vantage Health Inc., ("Vantage Health") or (the "Company") today announced that it has entered into a strategic partnership with Theranostics Laboratory, a translational research company, with offices in the USA and New Zealand. [More]
Researchers Analyze Role of Nanostructures Around Brain Cells

Researchers Analyze Role of Nanostructures Around Brain Cells

Freiburg researchers decipher the role of nanostructures around brain cells in central nervous system function [More]

News Categories